Integral Ad Science (NASDAQ:IAS – Free Report) had its price target decreased by Craig Hallum from $18.00 to $16.00 in a report published on Wednesday,Benzinga reports. Craig Hallum currently has a buy rating on the stock.
Several other equities analysts also recently issued reports on IAS. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Monday, August 5th. Oppenheimer decreased their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday. Raymond James boosted their price objective on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Barclays boosted their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Finally, Morgan Stanley boosted their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 23rd. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $15.70.
View Our Latest Stock Analysis on IAS
Integral Ad Science Stock Down 6.1 %
Integral Ad Science (NASDAQ:IAS – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same quarter in the prior year, the company earned ($0.09) EPS. The company’s revenue was up 11.0% compared to the same quarter last year. On average, sell-side analysts forecast that Integral Ad Science will post 0.25 earnings per share for the current fiscal year.
Insider Transactions at Integral Ad Science
In related news, CEO Lisa Utzschneider sold 10,481 shares of the company’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now owns 239,709 shares in the company, valued at $2,423,457.99. This represents a 4.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Tania Secor sold 5,240 shares of the company’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the sale, the chief financial officer now owns 248,223 shares in the company, valued at approximately $2,509,534.53. The trade was a 2.07 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 23,006 shares of company stock worth $240,296. 2.00% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in IAS. Swiss National Bank grew its holdings in shares of Integral Ad Science by 30.2% in the first quarter. Swiss National Bank now owns 140,600 shares of the company’s stock valued at $1,402,000 after acquiring an additional 32,600 shares in the last quarter. ProShare Advisors LLC bought a new position in shares of Integral Ad Science in the first quarter worth $121,000. Jupiter Asset Management Ltd. bought a new position in shares of Integral Ad Science in the first quarter worth $3,257,000. Vanguard Group Inc. raised its position in shares of Integral Ad Science by 7.0% in the first quarter. Vanguard Group Inc. now owns 8,673,229 shares of the company’s stock worth $86,472,000 after buying an additional 566,982 shares in the last quarter. Finally, Ameritas Investment Partners Inc. raised its position in Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares in the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
- Five stocks we like better than Integral Ad Science
- Top Stocks Investing in 5G Technology
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Short Selling: How to Short a Stock
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Differences Between Momentum Investing and Long Term Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.